The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max Delbrück Center in Nature Microbiology.
AMP 2024 Q2 Earnings Release [CLEAN] 20240805 – Biotech Investments
Rancho Cucamonga, 08/07/2024 / 13:06, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Reports Net Revenues of $182.4 Million for the Three Months Ended June
August 8, 2024